Sanofi
SNY
582 hedge funds and large institutions have $9.15B invested in Sanofi in 2020 Q2 according to their latest regulatory filings, with 85 funds opening new positions, 185 increasing their positions, 194 reducing their positions, and 47 closing their positions.
170% more call options, than puts
Call options by funds: $49.2M | Put options by funds: $18.2M
81% more first-time investments, than exits
New positions opened: 85 | Existing positions closed: 47
12% more capital invested
Capital invested by funds: $8.2B → $9.15B (+$952M)
6% more funds holding
Funds holding: 547 → 582 (+35)
0.66% less ownership
Funds ownership: 14.93% → 14.28% (-0.66%)
5% less repeat investments, than reductions
Existing positions increased: 185 | Existing positions reduced: 194
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$168M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$60.7M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$59.6M |
| 4 |
BlackRock
New York
|
+$28.9M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$24M |
Top Sellers
| 1 |
Dodge & Cox
San Francisco,
California
|
-$419M |
| 2 |
JP Morgan Chase
New York
|
-$86.1M |
| 3 |
SJIC
St. James Investment Company
Southlake,
Texas
|
-$53M |
| 4 |
Morgan Stanley
New York
|
-$51.5M |
| 5 |
BCPEMI
Bain Capital Public Equity Management II
Boston,
Massachusetts
|
-$48.4M |
SNY Hedge Fund Activity: Q2 2020 in Review
582 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Sanofi (SNY) for Q2 2020, worth a combined $9.15B — up 12% from $8.2B a quarter earlier.
Buyers outnumbered sellers: 85 funds opened new SNY positions and 47 closed out — a net gain of 38 holders — while 185 added to existing stakes and 194 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $168M. The largest seller was Dodge & Cox, cutting an estimated $419M.
- 582 institutional investors held Sanofi (SNY) as of Q2 2020, up from 547 in Q1 2020.
- Funds reported $9.15B of Sanofi stock for Q2 2020, up 12% quarter-over-quarter.
- 85 funds opened new Sanofi positions in Q2 2020 and 47 closed out, a net change of +38 holders.
- The largest Sanofi buyer in Q2 2020 was Fidelity Investments, an estimated $168M added.
- The largest Sanofi seller in Q2 2020 was Dodge & Cox, an estimated $419M sold.
Based on aggregated 13F filings for Q2 2020.